Blog
Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates
Femasys Inc. (FEMY) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.21 per share a year ago. These figures are
Phunware (PHUN) Reports Q2 Loss, Misses Revenue Estimates
Phunware (PHUN) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.32 per share a year ago. These figures are
Top Stock Reports for JPMorgan Chase, Chevron & Shopify
Friday, August 8, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including JPMorgan
Signal vs Noise: Your Path to Profitability
One of the inherent characteristics of youth is curiosity. For example, when little kids ask their parents, “Why is the sky blue?” they are curious about the world and seek a simple, satisfying
Is Archer Aviation Stock a Buy, Hold, or Sell Before Q2 Earnings?
Archer Aviation Inc. ACHR shares have surged 169.2% over the past year, significantly outpacing the Aerospace - Defense industry’s rally of 16.1%. Consequently, many investors who haven't yet
IonQ Secures $1.6 Billion to Power Quantum Projects: Is It a Buy Now?
IonQ’s IONQ second quarter of 2025 marked a major turning point for the quantum computing giant in several ways. On the computing side, IonQ is accelerating toward 800 logical qubits by 2027 and
Compared to Estimates, Monster Beverage (MNST) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2025, Monster Beverage (MNST) reported revenue of $2.11 billion, up 11.1% over the same period last year. EPS came in at $0.52, compared to $0.41 in the year-ago quarter.
Here's What Key Metrics Tell Us About Sweetgreen (SG) Q2 Earnings
For the quarter ended June 2025, Sweetgreen, Inc. (SG) reported revenue of $185.58 million, up 0.5% over the same period last year. EPS came in at -$0.20, compared to -$0.13 in the year-ago quarter.
Carlyle Touches 52-Week High: How to Approach the Stock Now?
The Carlyle Group Inc. CG shares touched a new 52-week high of $64.09 during yesterday's trading session. The stock closed the session a little lower at $61.57.
CG’s shares have gained 57.5% in the
Monster Beverage Q2 Earnings Beat, Higher Sales Across Most Segments Aid
Monster Beverage Corporation (MNST) delivered solid second-quarter 2025 earnings, wherein the bottom line beat the Zacks Consensus Estimate and increased year over year.
The company has seen growth
Compared to Estimates, Datadog (DDOG) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2025, Datadog (DDOG) reported revenue of $826.76 million, up 28.1% over the same period last year. EPS came in at $0.46, compared to $0.43 in the year-ago quarter.
The
Pediatrix Medical's Q2 Earnings Beat on Strong Patient Volumes
Shares of Pediatrix Medical Group, Inc. MD have gained 12.1% since it reported second-quarter 2025 results on Aug. 5. The quarterly results were aided by higher patient volumes, improved patient
Can ConocoPhillips' Strategic Divestments Support Long-Term Growth?
ConocoPhillips COP is a leading player in the energy sector, primarily involved in exploration and production activities, with a strong global presence. The company highlights that it has a durable
Citizens & Northern (CZNC) Misses Q2 Earnings Estimates
Citizens & Northern (CZNC) came out with quarterly earnings of $0.4 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.4 per share a year ago. These
Crocs Q2 Earnings Surpass Estimates, Revenues Increase 3.4%
Crocs, Inc. CROX has reported strong second-quarter 2025 results, wherein the top line was in line with the Zacks Consensus Estimate, while the bottom line surpassed the estimates. Meanwhile, both
Vistra Q2 Earnings Beat Estimates, Revenues Miss, Both Up Y/Y
Vistra Corp. VST reported second-quarter 2025 earnings of $1.01 per share, which beat the Zacks Consensus Estimate of 98 cents by 3.1%. In the year-ago quarter, the company reported earnings of 90
Compared to Estimates, Sotera Health (SHC) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2025, Sotera Health Company (SHC) reported revenue of $294.34 million, up 6.4% over the same period last year. EPS came in at $0.20, compared to $0.19 in the year-ago
Restaurant Brands Q2 Earnings Miss Estimates, Rise Y/Y, Stock Down
Restaurant Brands International, Inc. QSR reported mixed second-quarter 2025 results, with earnings missing the Zacks Consensus Estimate but increasing on a year-over-year basis. Meanwhile, net
IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi
Iovance Biotherapeutics IOVA incurred a second-quarter 2025 loss of 33 cents per share, wider than the Zacks Consensus Estimate of a loss of 29 cents. In the year-ago quarter, the company reported a
Here is Why Growth Investors Should Buy SunOpta (STKL) Now
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth
Is Idexx (IDXX) a Solid Growth Stock? 3 Reasons to Think "Yes"
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to
3 Reasons Why Growth Investors Shouldn't Overlook Griffon (GFF)
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth
Is Universal Technical (UTI) a Solid Growth Stock? 3 Reasons to Think "Yes"
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth
Looking for a Growth Stock? 3 Reasons Why Sprouts Farmers (SFM) is a Solid Choice
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great
Looking for a Growth Stock? 3 Reasons Why Fabrinet (FN) is a Solid Choice
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth


